Federal Register / Vol. 69, No. 198 / Thursday, October 14, 2004 / Notices 61045

Drug Schedule 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................ II 

Benzoylecgonine (9180) ............... II 

Ethylmorphine (9190) ................... II 

Meperidine (9230) ........................ II 

Methadone (9250) ........................ II 

Dextropropoxyphene, bulk (nondosage forms) (9273) ............... II 

Morphine (9300) ........................... II 

Thebaine (9333) ........................... II 

Levo-alphacetylmethadol (9648) .. II 

Oxymorphone (9652) .................... II 

The company plans to import small 

quantities of the listed controlled 

substances for the manufacture of 

analytical reference standards. 

Any manufacturer who is presently, 

or is applying to be, registered with DEA 

to manufacture such basic classes of 

controlled substances may file 

comments or objections to the issuance 

of the proposed registration and may, at 

the same time, file a written request for 

a hearing on such application pursuant 

to 21 CFR 1301.43 and in such form as 

prescribed by 21 CFR 1316.47. 

Any such comments or objections or 

requests for hearing may be addressed, 

in quintuplicate, to the Deputy Assistant 

Administrator, Office of Diversion 

Control, Drug Enforcement 

Administration, United States 

Department of Justice, Washington, DC 

20537, Attention: DEA Federal Register

Representative (CCD) and must be filed 

no later than November 15, 2004. 

This procedure is to be conducted 

simultaneously with and independent 

of the procedures described in 21 CFR 

1301.34(b), (c), (d), (e) and (f). 

As noted in a previous notice 

published in the Federal Register on 

September 23, 1975, (40 FR 43745–46), 

all applicants for registration to import 

a basic class of any controlled 

substances in Schedule I or II are and 

will continue to be required to 

demonstrate to the Deputy Assistant 

Administrator, Office of Diversion 

Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a), 21 U.S.C. 823(a), and 21 

CFR 1301.34(b), (c),(d),(e) and (f) are 

satisfied.

Dated: September 28, 2004. 

William J. Walker, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration.

[FR Doc. 04–23054 Filed 10–13–04; 8:45 am] 

BILLING CODE 4410–09–P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated March 29, 2004, and 

published in the Federal Register on 

April 29, 2004, (69 FR 23537–23538), 

Cody Laboratories, Inc., 601 

Yellowstone Avenue, Cody, Wyoming 

82414, made application by letter to the 

Drug Enforcement Administration 

(DEA) to be registered as a bulk 

manufacturer of Cocaine (9041), a basic 

class of controlled substance in 

Schedule II. 

The company plans to manufacture 

the product in bulk to distribute to its 

customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of Cody 

Laboratories, Inc. to manufacture the 

basic class of controlled substance listed 

is consistent with the public interest at 

this time. DEA has investigated Cody 

Laboratories, Inc. to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed.

Dated: September 28, 2004. 

William J. Walker, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration.

[FR Doc. 04–23055 Filed 10–13–04; 8:45 am] 

BILLING CODE 4410–09–P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated April 9, 2004, and 

published in the Federal Register on 

April 26, 2004, (69 FR 22566), Penick, 

Corporation, 158 Mount Olivet Avenue, 

Newark, New Jersey 07114, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

the basic classes of controlled 

substances:

Drug Schedule 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................ II 

Diphenoxylate (9170) ................... II 

Ecgonine (9180) ........................... II 

Hydrocodone (9193) ..................... II 

Morphine (9300) ........................... II 

Thebaine (9333) ........................... II 

Oxymorphone (9652) .................... II 

The company plans to manufacture 

bulk controlled substances and noncontrolled substance flavor extracts. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Penick Corporation to manufacture the 

listed basic classes of controlled 

substances is consistent with the public 

interest at this time. DEA has 

investigated Penick Corporation to 

ensure that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed.

Dated: September 28, 2004. 

William J. Walker, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration.

[FR Doc. 04–23060 Filed 10–13–04; 8:45 am] 

BILLING CODE 4410–09–P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

Notice dated June 1, 2004, and 

published in the Federal Register on 

June 16, 2004, (69 FR 33666), Siegfried 

(USA), Inc., Industrial Park Road, 

Pennsville, New Jersey 08070, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

Methadone Intermediate (9254), a basic 

class of controlled substance in 

Schedule II. 

The company plans to manufacture 

the listed controlled substance for